Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
360 hedge funds and large institutions have $1.4B invested in Avanos Medical in 2016 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 101 increasing their positions, 112 reducing their positions, and 32 closing their positions.
34% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 32
14% more call options, than puts
Call options by funds: $2.47M | Put options by funds: $2.16M
10% more capital invested
Capital invested by funds: $1.28B → $1.4B (+$125M)
2.57% more ownership
Funds ownership: 84.3% → 86.87% (+2.6%)
2% more funds holding
Funds holding: 352 → 360 (+8)
10% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 112
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$18.7M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$18.2M |
| 3 |
Goldman Sachs
New York
|
+$15.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.6M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$13.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shapiro Capital Management
Atlanta,
Georgia
|
-$63M |
| 2 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$24.4M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$13.8M |
| 4 |
Millennium Management
New York
|
-$11.2M |
| 5 |
LCP
Lombardia Capital Partners
Pasadena,
California
|
-$10.5M |
AVNS Hedge Fund Activity: Q3 2016 in Review
360 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2016, worth a combined $1.4B — up 9.8% from $1.28B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new AVNS positions and 32 closed out — a net gain of 11 holders — while 101 added to existing stakes and 112 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $18.7M. The largest seller was Shapiro Capital Management, cutting an estimated $63M.
- 360 institutional investors held Avanos Medical (AVNS) as of Q3 2016, up from 352 in Q2 2016.
- Funds reported $1.4B of Avanos Medical stock for Q3 2016, up 9.8% quarter-over-quarter.
- 43 funds opened new Avanos Medical positions in Q3 2016 and 32 closed out, a net change of +11 holders.
- The largest Avanos Medical buyer in Q3 2016 was JP Morgan Chase, an estimated $18.7M added.
- The largest Avanos Medical seller in Q3 2016 was Shapiro Capital Management, an estimated $63M sold.
Based on aggregated 13F filings for Q3 2016.